blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1809303

EP1809303 - PHARMACEUTICAL COMPOSITIONS AND METHODS RELATING TO INHIBITING FIBROUS ADHESIONS OR INFLAMMATORY DISEASE USING LOW SULPHATE FUCANS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.01.2020
Database last updated on 16.09.2024
FormerThe patent has been granted
Status updated on  01.02.2019
FormerGrant of patent is intended
Status updated on  03.12.2018
FormerExamination is in progress
Status updated on  29.11.2016
Most recent event   Tooltip09.07.2021Lapse of the patent in a contracting state
New state(s): HU		published on 11.08.2021  [2021/32]
Applicant(s)For all designated states
ARC Medical Devices, Inc.
102- 2386 East Mall
Vancouver BC V6T 1Z3 / CA
[2013/08]
Former [2007/30]For all designated states
ARC PHARMACEUTICALS, INC.
102, 2386 East Mall
Vancouver, British Columbia V6T 1Z3 / CA
Inventor(s)01 / CASHMAN, Johanne
6070 Blenheim Street
Vancouver, British Columbia V6N 1R1 / CA
02 / SPRINGATE, Christopher
556 East 12th Avenue
Vancouver, British Columbia V5T 2H5 / CA
03 / WINTERNITZ, Charles
7215 Montabor Drive
Colorado Springs CO 80918-4757 / CA
 [2007/42]
Former [2007/30]01 / CASHMAN, Johanne
6070 Blenheim Street
Vancouver, British Columbia V6N 1R1 / CA
02 / SPRINGATE, Christopher
556 East 12th Avenue
Vancouver, British Columbia V5T 2H5 / CA
03 / WINTERNITZ, Charles
4576 61st Street
Delta, British Columbia V4K 3L2 / CA
Representative(s)Stolmár & Partner Patentanwälte PartG mbB
Blumenstraße 17
80331 München / DE
[2019/10]
Former [2007/30]Stolmár, Matthias, et al
Stolmár Scheele & Partner Blumenstrasse 17
80331 München / DE
Application number, filing date05788866.123.09.2005
[2007/30]
WO2005CA01446
Priority number, dateUS20040612665P23.09.2004         Original published format: US 612665 P
US20040612676P23.09.2004         Original published format: US 612676 P
[2007/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006032143
Date:30.03.2006
Language:EN
[2006/13]
Type: A1 Application with search report 
No.:EP1809303
Date:25.07.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 30.03.2006 takes the place of the publication of the European patent application.
[2007/30]
Type: B1 Patent specification 
No.:EP1809303
Date:06.03.2019
Language:EN
[2019/10]
Search report(s)International search report - published on:CA30.03.2006
(Supplementary) European search report - dispatched on:EP20.11.2008
ClassificationIPC:A61K31/737, A61K36/03, A61P17/02, A61P29/00, A61P43/00, A61P41/00, A61K9/70, A61K47/36, A61L31/04, C08L5/00
[2018/51]
CPC:
A61K31/737 (EP,US); A61K31/436 (US); A61K31/711 (US);
A61K36/03 (EP,US); A61L31/042 (EP,US); A61L31/16 (US);
A61P17/02 (EP,US); A61P29/00 (EP,US); A61P41/00 (EP,US);
A61P43/00 (EP,US); C08L5/00 (US); A61L2300/41 (US);
A61L2300/43 (US) (-)
C-Set:
A61L31/042, C08L5/00 (EP,US)
Former IPC [2007/30]A61K31/737, A61P29/00, A61P41/00, A61K31/711, A61K31/436, A61K9/70, A61K47/36
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2019/10]
Former [2007/30]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERFAHREN ZUR HEMMUNG VON FIBRÖSER ADHÄSION ODER ENTZÜNDUNGSERKRANKUNG MIT NIEDERMOLEKULAREN SULFAT-FUCANEN[2007/30]
English:PHARMACEUTICAL COMPOSITIONS AND METHODS RELATING TO INHIBITING FIBROUS ADHESIONS OR INFLAMMATORY DISEASE USING LOW SULPHATE FUCANS[2007/30]
French:COMPOSITIONS PHARMACEUTIQUES ET METHODES RELATIVES A L'INHIBITION D'ADHERENCES FIBREUSES OU DE MALADIES INFLAMMATOIRES A L'AIDE DE FUCANES A BASSE TENEUR EN SULFATE[2007/30]
Entry into regional phase20.04.2007National basic fee paid 
20.04.2007Search fee paid 
20.04.2007Designation fee(s) paid 
20.04.2007Examination fee paid 
Examination procedure20.04.2007Amendment by applicant (claims and/or description)
20.04.2007Examination requested  [2007/30]
11.03.2009Despatch of a communication from the examining division (Time limit: M06)
16.09.2009Reply to a communication from the examining division
07.06.2010Despatch of a communication from the examining division (Time limit: M06)
07.12.2010Reply to a communication from the examining division
08.02.2012Despatch of a communication from the examining division (Time limit: M06)
16.08.2012Reply to a communication from the examining division
23.03.2015Despatch of a communication from the examining division (Time limit: M06)
02.10.2015Reply to a communication from the examining division
22.02.2016Despatch of a communication from the examining division (Time limit: M08)
30.11.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
08.02.2017Reply to a communication from the examining division
27.02.2018Despatch of a communication from the examining division (Time limit: M04)
09.07.2018Reply to a communication from the examining division
04.12.2018Communication of intention to grant the patent
24.01.2019Fee for grant paid
24.01.2019Fee for publishing/printing paid
24.01.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.03.2009
Opposition(s)09.12.2019No opposition filed within time limit [2020/07]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
08.02.2017Request for further processing filed
08.02.2017Full payment received (date of receipt of payment)
Request granted
17.02.2017Decision despatched
Fees paidRenewal fee
24.09.2007Renewal fee patent year 03
26.09.2008Renewal fee patent year 04
28.09.2009Renewal fee patent year 05
28.10.2010Renewal fee patent year 06
27.09.2011Renewal fee patent year 07
28.09.2012Renewal fee patent year 08
30.09.2013Renewal fee patent year 09
30.09.2014Renewal fee patent year 10
30.09.2015Renewal fee patent year 11
30.09.2016Renewal fee patent year 12
30.09.2017Renewal fee patent year 13
01.10.2018Renewal fee patent year 14
Penalty fee
Additional fee for renewal fee
30.09.201006   M06   Fee paid on   28.10.2010
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.09.2005
CY06.03.2019
CZ06.03.2019
EE06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
RO06.03.2019
SI06.03.2019
SK06.03.2019
BG06.06.2019
GR07.06.2019
IS06.07.2019
LU23.09.2019
[2021/32]
Former [2021/26]CY06.03.2019
CZ06.03.2019
EE06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
RO06.03.2019
SI06.03.2019
SK06.03.2019
BG06.06.2019
GR07.06.2019
IS06.07.2019
LU23.09.2019
Former [2020/35]CZ06.03.2019
EE06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
RO06.03.2019
SI06.03.2019
SK06.03.2019
BG06.06.2019
GR07.06.2019
IS06.07.2019
LU23.09.2019
Former [2020/25]CZ06.03.2019
EE06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
RO06.03.2019
SI06.03.2019
SK06.03.2019
BG06.06.2019
GR07.06.2019
IS06.07.2019
Former [2020/13]CZ06.03.2019
EE06.03.2019
LT06.03.2019
LV06.03.2019
RO06.03.2019
SI06.03.2019
SK06.03.2019
BG06.06.2019
GR07.06.2019
IS06.07.2019
Former [2020/04]CZ06.03.2019
EE06.03.2019
LT06.03.2019
LV06.03.2019
RO06.03.2019
SK06.03.2019
BG06.06.2019
GR07.06.2019
IS06.07.2019
Former [2019/49]CZ06.03.2019
EE06.03.2019
LT06.03.2019
LV06.03.2019
RO06.03.2019
SK06.03.2019
BG06.06.2019
GR07.06.2019
Former [2019/39]LT06.03.2019
LV06.03.2019
BG06.06.2019
GR07.06.2019
Former [2019/38]LT06.03.2019
BG06.06.2019
GR07.06.2019
Former [2019/37]LT06.03.2019
GR07.06.2019
Former [2019/33]LT06.03.2019
Documents cited:Search[PX]WO2004105737  (ARC PHARMACEUTICALS INC [CA], et al) [PX] 1-14,20 * paragraphs [0003] - [0007] * * paragraphs [0010] , [0014] - [0016] * * paragraphs [0017] , [0031] - [0041] * * paragraphs [0105] - [0119] * * figures 1-5 * * examples 11-15 * * claims 59-61,64-66,68,69 * * claims 71,74,75,85,89-94,96,97,99-102,106,107,113,115 * * claims 121-124,127-129 *;
 [E]WO2006020994  (ANGIOTECH INT AG [CH], et al) [E] 1-8,10,11,13-20 * page 6, line 4 - line 7 * * page 7, line 25 * * page 23, line 24 - page 24, line 2 * * page 49, line 21 - line 22 * * page 51, line 19 - line 23 * * page 52, line 20 - line 28 * * page 53, line 6 - line 28 * * page 54, line 19 - line 30 * * page 55, line 1 - line 4 * * page 92, line 13 - line 19; example 15 * * page 92, line 30 - page 94, line 6 * * example 16 * * page 94, line 16 - line 21 * * page 96, line 3 - line 10 * * page 98, line 3 - line 12 * * page 98, line 26 - page 99, line 27 * * page 108, line 8 - line 14; example 19 ** claims 9,10,72,78,88,95,96 *
International search[X]CA1297791  (ETHICON INC [US]);
 [X]CA1330298  (THOMAE GMBH DR K [DE]);
 [X]US5534261  (RODGERS KATHLEEN E [US], et al);
 [X]CA2223573  (UNIV SOUTHERN CALIFORNIA [US]);
 [X]WO9724459  (ZYNAXIS INC [US]);
 [X]CA2367107  (UNIV SOUTHERN CALIFORNIA [US]);
 [X]WO0056283  (GOODRICH CO B F [US]);
 [X]CA2458853  (UNIV BRITISH COLUMBIA [CA]);
 [X]WO2004020473  (LG LIFE SCIENCES LTD [KR], et al);
by applicantUS3687808
 US4469863
 US4476301
 US4587044
 US4605735
 US4667025
 US4762779
 US4789737
 US4824941
 US4828979
 US4835263
 US4845205
 US4876335
 US4904582
 US4948882
 US4958013
 US4981957
 US5023243
 US5034506
 US5082830
 US5109124
 US5112963
 US5118800
 US5118802
 US5130302
 US5134066
 US5138045
 US5166315
 US5175273
 US5177196
 US5185444
 US5188897
 US5214134
 US5214136
 US5216141
 US5218105
 US5235033
 US5245022
 US5254469
 US5258506
 US5262536
 US5264423
 US5264562
 US5264564
 WO9324510
 US5272250
 US5276019
 US5278302
 US5286717
 US5292873
 US5317098
 US5319080
 US5321131
 US5359044
 US5367066
 US5371241
 US5391723
 US5393878
 US5399676
 US5405939
 US5405938
 US5414077
 US5416203
 US5432272
 US5434257
 US5446137
 US5451463
 US5453496
 US5455233
 US5457187
 US5459255
 US5466677
 US5466786
 US5470967
 US5476925
 US5484908
 US5486603
 US5489677
 US5502177
 US5510475
 US5512439
 US5512667
 US5514785
 US5519126
 US5519134
 US5525711
 US5525465
 US5536821
 US5539082
 US5541306
 US5541307
 US5541313
 US5545730
 US5550111
 US5552540
 US5552538
 US5561225
 US5563253
 US5565552
 US5567811
 US5567810
 US5571799
 US5574142
 US5576427
 US5578717
 US5578718
 US5580731
 US5585481
 US5587361
 US5587469
 US5587371
 US5591722
 US5591584
 US5594121
 US5596086
 US5596091
 US5595726
 US5597909
 US5597696
 US5599923
 US5599928
 US5602240
 US5608046
 US5610289
 US5610300
 US5614617
 US5618704
 US5623070
 US5625050
 US5627053
 US5633360
 US5639873
 US5646265
 US5658873
 US5663312
 US5670633
 US5677437
 US5677439
 US5681941
 US5688941
 US5700920
 US5714331
 US5719262
 WO03018033
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.